Scientific Director
Novo Nordisk A/S
Maaleov, Denmark
Philip Jonas Sassene has a strong track record in pharmaceutical formulation and drug delivery. He has 10+ years of experience in solid and enabling formulations, including preformulation together with a thorough understanding of the physiology of the gastrointestinal tract. This includes in particular the development of new enabling formulation strategies for oral delivery of peptides & proteins. Philip Jonas Sassene received his PhD in pharmaceutical sciences in 2016 from the University of Copenhagen, Denmark. He is currently employed as a Scientific Director within oral delivery technologies at Novo Nordisk A/S, Denmark.
Disclosure information not submitted.
Plenary Duet III Oral Delivery of Biologics Challenges, Opportunities, and Clinical Successes
Thursday, July 11, 2024
12:00 PM – 1:30 PM CET
